These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients? Morré SA, De Groot CJ, Killestein J, Meijer CJ, Polman CH, Van der Valk P, Van den Brule AJ. Ann Neurol; 2000 Sep; 48(3):399. PubMed ID: 10976651 [No Abstract] [Full Text] [Related]
7. Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Munger KL, Peeling RW, Hernán MA, Chasan-Taber L, Olek MJ, Hankinson SE, Hunter D, Ascherio A. Epidemiology; 2003 Mar; 14(2):141-7. PubMed ID: 12606878 [Abstract] [Full Text] [Related]
8. Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis. Sriram S, Ljunggren-Rose A, Yao SY, Whetsell WO. J Infect Dis; 2005 Oct 01; 192(7):1219-28. PubMed ID: 16136465 [Abstract] [Full Text] [Related]
9. [Infectious agents in the pathogenesis of multiple sclerosis]. Szczuciński A, Losy J. Przegl Epidemiol; 2006 Oct 01; 60 Suppl 1():160-5. PubMed ID: 16909795 [Abstract] [Full Text] [Related]
14. Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms. Fainardi E, Castellazzi M, Casetta I, Cultrera R, Vaghi L, Granieri E, Contini C. J Neurol Sci; 2004 Feb 15; 217(2):181-8. PubMed ID: 14706222 [Abstract] [Full Text] [Related]
15. The pathology of multiple sclerosis. Sobel RA. Neurol Clin; 1995 Feb 15; 13(1):1-21. PubMed ID: 7739499 [Abstract] [Full Text] [Related]
20. [Immunity and neurodegeneration: new concepts in multiple sclerosis]. Lalive PH, Schluep M, Chofflon M, Du Pasquier R. Rev Med Suisse; 2006 May 03; 2(64):1166-8, 1170. PubMed ID: 16734188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]